 TriLink enables Chula VRC to take its Covid-19 vaccine into a First in Human FIH phase 1 clinical trial in Thailand with mRNA manufacturing process development and its proprietary mRNA capping technology, ushering a much-needed vaccine into economically developing countries TriLink enables Chula VRC to take its Covid-19 vaccine into a First in Human FIH phase 1 clinical trial in Thailand with mRNA manufacturing process development and its proprietary mRNA capping technology, ushering a much-needed vaccine into economically developing countries 